Nissay Asset Management Corp Japan ADV lifted its position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 82,523 shares of the company’s stock after acquiring an additional 857 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Avantor were worth $1,767,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB raised its position in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after acquiring an additional 830 shares during the last quarter. Global Retirement Partners LLC raised its position in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after acquiring an additional 1,067 shares during the last quarter. UMB Bank n.a. raised its position in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after acquiring an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC bought a new stake in shares of Avantor during the fourth quarter worth $65,000. Institutional investors own 95.08% of the company’s stock.
Insider Transactions at Avantor
In other news, EVP James Bramwell sold 3,758 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This represents a 4.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. This represents a 10.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Get Our Latest Report on Avantor
Avantor Stock Up 4.3%
NYSE:AVTR opened at $13.40 on Friday. Avantor, Inc. has a 1 year low of $11.82 and a 1 year high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The stock has a market cap of $9.13 billion, a price-to-earnings ratio of 12.88, a PEG ratio of 1.55 and a beta of 1.09. The stock has a 50-day moving average price of $14.76 and a two-hundred day moving average price of $18.59.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.23. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same period in the previous year, the firm earned $0.22 earnings per share. The company’s revenue was down 5.9% on a year-over-year basis. As a group, equities analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- Short Selling – The Pros and Cons
- Top 4 ETFs for China Exposure After Tariff Relief
- ETF Screener: Uses and Step-by-Step Guide
- Build a Complete Bond Portfolio With These 4 ETFs
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 05/12 – 05/16
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.